Navigation Links
Ferumoxytol in Medical News

New form of intravenous iron treats anemia in chronic kidney disease patients on dialysis

...ective alternative to other forms of iron therapy. ferumoxytol appears to contain less free iron and be less immu...nducted a phase three clinical trial that compared ferumoxytol with oral iron. The trial enrolled 230 anemic pati... Patients received either two injections of 510 mg ferumoxytol within seven days or 200 mg oral iron daily for 21...

Satellite Healthcare Will Present at the American Society of Nephrology's Renal Week – Booth 527 : November 4-9, 2008

...ing Thrice Weekly or More Frequent HD presented by Bhupinder Virk, MD; Sheila Doss, RN; John Moran, MB, BS; Brigitte Schiller, MD Efficacy of IV ferumoxytol in CKD Patients with Persistent Anemia Despite Oral Iron Therapy presented by Brigitte Schiller, MD: Paul Miller, Jiannong Liu, Robert Brenner and Rob...
Ferumoxytol in Medical Technology

Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings

CAMBRIDGE, Mass., March 06, 2007 /PRNewswire-FirstCall/ -- Advanced Magnetics today announced that data from three completed Phase III multi- center clinical studies of ferumoxytol as an intravenous iron replacement therapeutic will be presented during the National Kidney Foundation (NKF) 2007 Spr...

Advanced Magnetics Announces Positive Results from Two Additional Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement Therapeutic

CAMBRIDGE, Mass., April 11, 2007 /PRNewswire-FirstCall/ -- Advanced Magnetics today announced positive results from two additional Phase III clinical trials of ferumoxytol as an intravenous (IV) iron replacement therapeutic that are being presented today at approximately 6:00 pm EDT as posters at ...
Ferumoxytol in Biological Technology

AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China

SHENYANG, China, May 28 /Xinhua-PRNewswire-FirstCall/ -- AMAG Pharmaceuticals, Inc. (Nasdaq: AMAG ) and 3SBio, Inc. (Nasdaq: SSRX ), a leading Chinese biotechnology company, today announced the signing of a development and commercialization agreement for ferumoxytol, an intravenous iron repl...

3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2008 Results

...hree new product programs; 36,000 IU dosage formulation of EPIAO, NuLeusin, and TPIAO label extension for the treatment of ITP. -- Initiate ferumoxytol registration trial in China, following US FDA approval. -- Submit application for clinical trials of NuPIAO, the Company's second ge...

BioTrends Releases TreatmentTrends(TM): Nephrology and Renal Dietitians, Two Syndicated Reports Providing Continuing Insight into the Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism

...Venofer to increase following the news that Fresenius will be marketing and distributing Venofer in dialysis units. Awareness of AMAG Pharmaceutical's ferumoxytol continues to be low. Among those familiar with the product, expected benefits center around dosing and administration, particularly for CKD patients. ...

3SBio Inc. Announces Second Quarter 2008 Results

...ess on the business development front, notably, the initiation of a strategic partnership with AMAG Pharmaceuticals, Inc. to develop and commercialize ferumoxytol and the rapid progression of our phase III programs in our portfolio." Second Quarter 2008 Unaudited Financial Results Net Revenues. Our net reven...

BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism

...e products to be differentiated, Venofer tends to have a perceived advantage on ease of administration in both dialysis and CKD. AMAG Pharmaceutical's ferumoxytol could be commercially available by the end of the year. Those with higher familiarity of the product, feel it has a dosing and administration advantag...

BioTrends Releases Fourth Annual Nephrology TreatmentTrends Publication Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism

...led an NDA for a new form of intravenous iron, ferumoxytol, which could be commercially available in the second half of 2008. Current familiarity with ferumoxytol is low, with 68% indicating that they are "not at all familiar" with the product. In the phosphate binder market, nephrologists seem to be in agreem...
Other Tags
(Date:7/22/2014)... 2014) With over 170,000 students now playing ... to injuries during practice and competition, according to a ... and the Center for Injury Research and Policy at ... published online today by The American Journal of ... experienced 1,406 injuries over the four academic years from ...
(Date:7/22/2014)... Garland’s new Energizer BK specially formulated cold-applied ... flood coat over new and existing asphalt and coal ... It provides natural resistance to moisture, chemicals, UV and ... Energizer BK is specially formulated with an asphalt coal ... to superior strength and flexibility. , The cold-applied ...
(Date:7/22/2014)... July 22, 2014 CareTouch Communications, Inc. ... CareTouch in the Community . CareTouch employees will select ... provide hands-on support in line with their mission to ... health. The program’s first cause is Hike for Hospice, ... , On Sunday, September 14, the CareTouch in the ...
(Date:7/22/2014)... 2014 Most people encounter the same two problems ... and the second is a fast metabolism. These are hard problems ... provides ways to help fight these problems and to finally gain ... people out there who just can’t seem to eat more than ... are full. The cause of this problem can vary. For some ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 A new ... address skin laxity with results that are surprising even ... topically treating the skin with radio frequency, ThermiTight has ... are inserted under the skin to “inject” heat to ... shown that this single treatment solution for skin laxity ...
Breaking Medicine News(10 mins):Health News:High school lacrosse players at risk of concussions other injuries 2Health News:High school lacrosse players at risk of concussions other injuries 3Health News:Energizer® BK Waterproof Coating from Garland Canada Reduces Life-Cycle Costs 2Health News:CareTouch is a Peak Sponsor for the 9th Annual Hike for Hospice in Morrison, Colorado 2Health News:CB-1 Weight Gainer Provides Two Tips to Help Customers Gain Weight 2Health News:New Minimally Invasive Procedure, ThermiTight, “Injects” Radio Frequency to Treat Skin Laxity 2
(Date:7/21/2014)... by neurobiologist Luke Remage-Healey at the University of ... the brains of young birds enhance their ability ... development. This period has a parallel to universal ... separate study, the UMass Amherst neuroscientist and colleagues ... the brain,s auditory cortex enhances the representation of ...
(Date:7/21/2014)... runoff is causing problems for the world,s water ... Agency found stormwater runoff to be one of ... rivers, streams, lakes, ponds, reservoirs, bays, and estuaries. ... fish and wildlife populations, foul drinking water, and ... Carolina State University are looking to rain gardens ...
(Date:7/21/2014)... Cystoid macular edema (CME) is a common complication ... in which patients typically lose night and side vision ... also decrease central vision. Current treatments for CME in ... adverse results. , Researchers from the Massachusetts Eye and ... Medicine tested whether the extent of retinal swelling due ...
Breaking Biology News(10 mins):Studying estrogens made by the brain may offer new insights in learning and memory 2Studying estrogens made by the brain may offer new insights in learning and memory 3Filter bed substrates, plant types recommended for rain gardens 2Iodine may alleviate swelling in retinitis pigmentosa patients' retinas 2
Other Contents